Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Dipotassium Glycyrrhizinate

Download as pdf or txt
Download as pdf or txt
You are on page 1of 11

DIPOTASSIUM GLYCYRRHIZINATE

070628

Components Of Licorice
Main Active Principle:
Glycyrrhizin (C42H62O16): 3 - 8% in the licorice root Responsible for its sweetness. Approx. 250 times as sweet as cane sugar.

Other well-known components:


Flavonoid glycosides, chalcone glycosides and isoflavonoids.
COOH
O

O
OH HO O O

COOH OO OH HO O COOH O OH HO OH
O HOH 2C OH OH

Liquiritin

Glycyrrhizin
MARUZEN PHARMACEUTICALS CO., LTD.

Review Of The Relevant Literature


Pharmacological & Physiological Effects 1. Detoxicant effect 2. Anti-ulcerative 3. Anti-inflammatory 4. Decholesterolization 5. Anti-estrogenic 6. Anti-tussive 7. Anti-histaminic 8. Anti-allergic hepatitis 9. Lowering blood sugar 10. Anti-leukemic 11. Anti-tumor 12. Anti-biotic
MARUZEN PHARMACEUTICALS CO., LTD.

Review Of The Relevant Literature


Three Main Actions of Licorice 1. Detoxicant effect
Synergistic effect of glycyrrhizinic acid and methionine to improve the liver function with GOT and GPT.

2. Anti-ulcerative effect
- Licorice extract: Anti-gastric and Anti-duodenal ulcerative effect - Fractions (FM100) other than glycyrrhizinic acid: Anti-ulcerative effect - Succinic acid ester made from glycyrrhetinic acid (Disodium 3-succinyloxy-Beta-glycyrrhetinate): Therapeutic agent for gastric ulcers

3. Anti-inflammatory effect
- Glycryyhetinic acid: More effective than hydrocortisone for subacute or chronic skin diseases. - Hydrocortisone antagonism: Mode of action of glycyrrhetinic acid against the physiological actions of hydrocortisone.
MARUZEN PHARMACEUTICALS CO., LTD.

Dipotassium Glycyrrhizinate (DPG)


COOH O

COOK OO OH HO O COOK O OH HO OH

C42H60K2O16

<Features> - Effective in treating acute and chronic dermatitis supported by many clinical reports both in Japan and abroad in the field of dermatology. - Milder action, almost without side effects. - Widely used in cosmetics because of its chemical stability, good solubility and emulsifying properties. - An anti-inflammatory active constituent in Quasi-Drug in Japan.
MARUZEN PHARMACEUTICALS CO., LTD.

Dipotassium Glycyrrhizinate (DPG)


<Description> White to faintly yellow crystalline powder, odorless,characteristic sweet taste <Stability> Heat: Very stable, but maybe decomposed if heated at over 100 degrees C for a long time. pH: When mineral acid is added to the aqueous solution of this product and drop pH under 4, the solution gels. <Solubility>
Solvents Water 50Ethanol Dehydrated ethanol 1,3-Butylene glycol Propylene glycol Chloroform Ether
MARUZEN PHARMACEUTICALS CO., LTD. : Very soluble : Insoluble

20

Inflammation
Cell Membrane

Mast Cell

Ca

IgE
Ca

Stimulation
Mucous Membrane

Phospholipids

Hyaluronidase (non-active

Hyaluronidase active

PLA2

Inflammation
Hyaluronidase inhibition

Redness, Edema, Fever, Pain, Dysfunction, etc.)


Capillary Vasodilation Edema

Arachidonic Acid Lipoxygenase Cyclooxygenase

Degranulation

LTs PGs
Edema FeverPain, etc

Histamine

Pain, Itchiness, Redness


Activation of Inflammatory Cell Vascular Permeability, etc Accelerate granular enzyme release MARUZEN PHARMACEUTICALS CO., LTD. Histamine release inhibition

Inhibition of LTB4 and PGE2 production

Inhibitory Effect on Hyaluronidase Activity


<Anti-inflammation and Hyaluronidase>
Inhibition of hyaluronidase plays an important role not only in maintaining the hyaluronic acid level in the body but also in anti-inflammatory and antiallergic activities.1) This enzyme is activated during inflammation, plays a role in the destruction of the connective tissue matrix, and increases the permeability of inflammatory cells and blood vessels. Hyaluronidase presents in mast cells in activated by the binding of IgE-antigen complex to receptors, and is involved in the release of histamine granules. So far anti-inflammatory agents such as indonethacin and antiallergic agents such as sodium cromoglicate have been reported as inhibitiors of hyaluronidase.

Sample DPG Indomethacin Sodium cromoglicate

IC50(g/mL) 3.4 39.0 11.0

DPG was 11 times stronger than indomethacin and 3 times greater than sodium cromoglicate as positive controls.
Ref: 1) Hisao Kakegawa, Chem Pharm Bull, Vol33 (9)3738-3744 (1985)

MARUZEN PHARMACEUTICALS CO., LTD.

Inhibitory Effects on Histamine Release

DPG: Inhibition 83.4% --- Conc. at 1mg/mL

DPG: Inhibition 86.4% --- Conc. at 2mg/mL

Ref: Tadayoshi Shibata, Journal of WakanMedical and Pharmaceutical Society for WAKAN-YAKU 6, 294 (1989) MARUZEN PHARMACEUTICALS CO., LTD.

Effects on Arachidonic Cascade

DPG: Significantly inhibited the LTB4 production


Ref: Norifumi Kawada, Inflammation 9(1), 29 (1989)

DPG: Significantly inhibited PGE2 production

MARUZEN PHARMACEUTICALS CO., LTD.

Clinical Study
Application Of Ointment With DPG For Atopic Dermatitis
Journal of New Remedies & Clinics Vol. 12, No.6 (1983)

Institute: Pediatric Department of Tochigi National Hospital Subject: 38 patients with atopic detmatitis (M: 17, F: 21) Test sample: Ointment with 1% DPG Application: Twice daily Evaluation: Objective symptom of skin rash, Subjective symptom of itching Result: In this clinical study, at least more than 15 days continuous application of the DPG-ointment is recommended. Number Significantly effective Effective No effect 6 16 16 42.1%
Among 22 patients with effectiveness: 15 patients- - - More than 15 days application 7 patients - - - Less than 15 days application MARUZEN PHARMACEUTICALS CO., LTD.

Effective % 57.9%

You might also like